SALEM INVESTMENT COUNSELORS INC
Position in GLAS — Glass House Brands Inc.
CIK 884423
WINSTON-SALEM, NC
Position in GLAS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$664,729
New position
Shares Held
51,133
first reported quarter
Ownership
0.054%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#22
of 53 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $1,287,735 across 14 Drug Manufacturers - Specialty & Generic names. GLAS ranks #1 (51.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLAS |
Glass House Brands Inc.
This page
|
51,133 | $664,729 | |
| 2 | VTRS |
Viatris Inc
|
13,446 | $213,522 | |
| 3 | DERM |
Journey Medical Corp
|
29,200 | $206,736 | |
| 4 | HLN |
Haleon plc
|
9,114 | $85,033 | |
| 5 | HROW |
Harrow, Inc.
|
1,300 | $55,211 | |
| 6 | ZTS |
Zoetis Inc.
|
586 | $42,109 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
400 | $13,868 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
200 | $2,000 |
All Filings in GLAS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $664,729 | 51,133 | Shares | Sole | 2026-07-14 | |
| No filing history on record for this holder in this stock. | ||||||